Insights

Rapid Market Expansion Lifebit is actively expanding its regional footprint with new offices in Tulsa, Oklahoma, and Singapore, indicating a strategic effort to penetrate North American and Asia Pacific markets. This growth opens opportunities for sales teams to engage local research institutions, pharmaceutical companies, and biotech firms seeking advanced genomics and data analysis solutions.

Innovative Data Security The recent launch of AI-Powered Federated Data Hubs demonstrates Lifebit's focus on secure, decentralized data collaboration without data exposure. This presents a sales opportunity to target organizations handling sensitive health data, such as hospitals, research bodies, and government agencies, that require robust data governance and privacy solutions.

Strong Investment Backing With a substantial $60 million Series B funding round led by Tiger Global Management, Lifebit shows significant financial strength and growth potential. This increases credibility and makes it an attractive partner for enterprises looking to invest in scalable and innovative genomics data platforms.

Strategic Partnerships Collaborations with Flatiron Health and PlumCare RWE highlight Lifebit’s positioning in the healthcare and real-world evidence domain. These partnerships can be leveraged to identify sales opportunities within oncology informatics, healthcare providers, and personalized medicine sectors that seek AI-driven data analysis tools.

Industry Leadership Lifebit’s role as a pioneer in open-source bioinformatics and its leadership in federated genomics demonstrate its competitive edge. It offers opportunities to connect with innovative research institutions, pharma companies, and biotech firms eager to adopt cutting-edge, AI-powered data analysis solutions for complex genomics projects.

Lifebit Tech Stack

Lifebit uses 8 technology products and services including Xero, HubSpot Analytics, Prometheus, and more. Explore Lifebit's tech stack below.

  • Xero
    Accounting
  • HubSpot Analytics
    Analytics
  • Prometheus
    Data Management
  • MySQL
    Database
  • Microsoft
    Miscellaneous
  • LinkedIn
    Online Community Software
  • Hadoop
    Programming Languages
  • Max Mega Menu
    Widgets

Media & News

Lifebit's Email Address Formats

Lifebit uses at least 1 format(s):
Lifebit Email FormatsExamplePercentage
First@lifebit.aiJohn@lifebit.ai
77%
First.Last@lifebit.aiJohn.Doe@lifebit.ai
16%
Last@lifebit.aiDoe@lifebit.ai
4%
First.Middle@lifebit.aiJohn.Michael@lifebit.ai
3%

Frequently Asked Questions

Where is Lifebit's headquarters located?

Minus sign iconPlus sign icon
Lifebit's main headquarters is located at 9 Appold Street London, England ec2a 2ap United Kingdom. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Lifebit's official website and social media links?

Minus sign iconPlus sign icon
Lifebit's official website is lifebit.ai and has social profiles on LinkedInCrunchbase.

What is Lifebit's SIC code NAICS code?

Minus sign iconPlus sign icon
Lifebit's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Lifebit have currently?

Minus sign iconPlus sign icon
As of February 2026, Lifebit has approximately 68 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Founder: M. C. D.Ceo And Founder: M. D.Chief Business Development Officer: T. S.. Explore Lifebit's employee directory with LeadIQ.

What industry does Lifebit belong to?

Minus sign iconPlus sign icon
Lifebit operates in the Biotechnology Research industry.

What technology does Lifebit use?

Minus sign iconPlus sign icon
Lifebit's tech stack includes XeroHubSpot AnalyticsPrometheusMySQLMicrosoftLinkedInHadoopMax Mega Menu.

What is Lifebit's email format?

Minus sign iconPlus sign icon
Lifebit's email format typically follows the pattern of First@lifebit.ai. Find more Lifebit email formats with LeadIQ.

How much funding has Lifebit raised to date?

Minus sign iconPlus sign icon
As of February 2026, Lifebit has raised $63M in funding. .

When was Lifebit founded?

Minus sign iconPlus sign icon
Lifebit was founded in 2017.

Lifebit

Biotechnology ResearchEngland, United Kingdom51-200 Employees

At Lifebit, we're pushing forward the frontiers of health and knowledge by democratising access to omics data. We enable all researchers, whether novice or advanced, to run complex analyses and generate meaningful insights fast. 

Lifebit CloudOS is the world’s first federated genomics platform for unified and secure research over distributed big data - wherever data resides. 

From top tier pharmaceutical organisations to global research institutes to genetics companies and more, Lifebit CloudOS leads the way with our best-in-class UX/UI, seamless integration to open-source tools, marketplace of proprietary ones, powerful cohort browser, and advanced AI functionality. 

At Lifebit, we are open source pioneers, innovators redefining our industry. Our driving mission - to revolutionise bioinformatics and biomedical data analysis forever. We are growing fast and looking for more superstars to join our team.

Section iconCompany Overview

Headquarters
9 Appold Street London, England ec2a 2ap United Kingdom
Website
lifebit.ai
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $63M

    Lifebit has raised a total of $63M of funding over 2 rounds. .

  • $25M$50M

    Lifebit's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $63M

    Lifebit has raised a total of $63M of funding over 2 rounds. .

  • $25M$50M

    Lifebit's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.